PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCERProstate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer are disclosed.SANGEETA RAYMARTIN G. POMPER
Stereotactic body radiotherapy (SBRT) has emerged as an effective treatment for localized prostate cancer. However, prostate specific antigen (PSA) kinetics after SBRT has not been well characterized. The objective of the current study is to analyze the rate of PSA decline and PSA nadir following ...
Prostate antigen levels in locally advanced prostate cancer patients treated with high energy neutrons at fermilabThe article presents several studies related to anti-aging medical approach to prostate cancer. These includes the study conducted at the Duke University Medical Center shows that consuming ...
Introduction High-risk prostate cancer is defined by the National Comprehensive Cancer Network (NCCN) as disease with a serum prostate-specific antigen (PSA) level greater than 20 nanograms per milliliter (ng/mL; to convert to μg/L, multiply by 1), a clinical T category 3 or 4, or a...
Findings A novel urine exosome assay plus standard of care (SOC) (prostate-specific antigen level, age, race, and family history) was statistically more predictive than SOC alone for predicting Gleason score of 7 (GS7) prostate cancer from GS 6 and benign disease. Meaning Use of a novel ur...
Twenty-one patients, or 66%, had an undetectable prostate-specific antigen (PSA) level 12 months following surgery, suggesting that there was no sign of residual disease. Additionally, the drug was well-tolerated overall; no patients had any surgical delays or medical complications during or after...
Purpose The purpose of this study was to evaluate the role of magnetic resonance spectroscopic imaging (MRSI) and dynamic contrast-enhanced magnetic resonance imaging ( DCE-MRI ) in detecting tumour foci in patients with elevated prostate-specific antigen (PSA) and negative transrectal ultrasonography ...
Objective: This study compared survival of prostate cancer patients with low prostate specific antigen level (PSA ≤ 10 ng/ml) and high-grades of Gleason score (GS) of 8–10 with different treatment options (i.e., radical prostatectomy [RP], external beam radiotherapy [EBRT...
(log base 2) between different groups. In addition, we evaluated the association of target gene expression with tumor stage, Gleason score, prostate-specific antigen (PSA), and the severity in TCGA dataset. To assess the potential association between target gene expression levels and prostate ...
“One important thing about ctDNA is the ability to get a positive or evaluable test depends on the prostate-specific antigen [PSA] level,” Antonarakis said. “ctDNA content increases with PSA level…In my practice, if a patient has metastatic disease with a PSA of less than 5 ng/mL,...